![]() |
Name |
acuminatum D
|
Molecular Formula | C41H65N7O10 | |
IUPAC Name* |
3-[3-butan-2-yl-22-decan-2-yl-6-[(4-hydroxyphenyl)methyl]-12,15-dimethyl-2,5,8,11,14,17,20-heptaoxo-1-oxa-4,7,10,13,16,19-hexazacyclodocos-9-yl]propanamide
|
|
SMILES |
CCCCCCCCC(C)C1CC(=O)NCC(=O)NC(C)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(C(C)CC)C(=O)O1
|
|
InChI |
InChI=1S/C41H65N7O10/c1-7-9-10-11-12-13-14-25(4)32-22-34(51)43-23-35(52)44-26(5)37(53)45-27(6)38(54)46-30(19-20-33(42)50)39(55)47-31(21-28-15-17-29(49)18-16-28)40(56)48-36(24(3)8-2)41(57)58-32/h15-18,24-27,30-32,36,49H,7-14,19-23H2,1-6H3,(H2,42,50)(H,43,51)(H,44,52)(H,45,53)(H,46,54)(H,47,55)(H,48,56)/t24-,25+,26-,27+,30-,31+,32-,36-/m0/s1
|
|
InChIKey |
HNBJBGLBRFZKFQ-FGIQGMPMSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 816.01 | ALogp: | 1.5 |
HBD: | 8 | HBA: | 10 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 264.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 58 | QED Weighted: | 0.094 |
Caco-2 Permeability: | -5.67 | MDCK Permeability: | 0.00005830 |
Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.975 |
Human Intestinal Absorption (HIA): | 0.521 | 20% Bioavailability (F20%): | 0.882 |
30% Bioavailability (F30%): | 0.996 |
Blood-Brain-Barrier Penetration (BBB): | 0.007 | Plasma Protein Binding (PPB): | 87.37% |
Volume Distribution (VD): | 0.358 | Fu: | 4.29% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.021 |
CYP2C19-inhibitor: | 0.07 | CYP2C19-substrate: | 0.044 |
CYP2C9-inhibitor: | 0.268 | CYP2C9-substrate: | 0.034 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.046 |
CYP3A4-inhibitor: | 0.801 | CYP3A4-substrate: | 0.065 |
Clearance (CL): | 3.005 | Half-life (T1/2): | 0.566 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.665 |
Drug-inuced Liver Injury (DILI): | 0.019 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.607 | Maximum Recommended Daily Dose: | 0.027 |
Skin Sensitization: | 0.034 | Carcinogencity: | 0.006 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.003 |
Respiratory Toxicity: | 0.002 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005271 | ![]() |
0.837 | D0M3FJ | ![]() |
0.420 | ||
ENC005275 | ![]() |
0.781 | D08FJL | ![]() |
0.402 | ||
ENC003950 | ![]() |
0.766 | D02SBQ | ![]() |
0.389 | ||
ENC005273 | ![]() |
0.750 | D0D8XY | ![]() |
0.382 | ||
ENC005272 | ![]() |
0.733 | D09PZZ | ![]() |
0.364 | ||
ENC005274 | ![]() |
0.723 | D0U7SH | ![]() |
0.349 | ||
ENC002514 | ![]() |
0.571 | D0M2YE | ![]() |
0.347 | ||
ENC003684 | ![]() |
0.531 | D0X9PF | ![]() |
0.346 | ||
ENC002515 | ![]() |
0.530 | D0N4OW | ![]() |
0.342 | ||
ENC003716 | ![]() |
0.498 | D09OOV | ![]() |
0.334 |